<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03415022</url>
  </required_header>
  <id_info>
    <org_study_id>#7598</org_study_id>
    <nct_id>NCT03415022</nct_id>
  </id_info>
  <brief_title>Computer-Based Treatment for Social Anxiety Disorder</brief_title>
  <official_title>A Novel Computer-Based Treatment for Social Anxiety: Target Engagement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is an open trial that seeks to examine the feasibility, acceptability,&#xD;
      mechanism, and efficacy of a recently developed computer-based therapy in individuals with&#xD;
      social anxiety disorder (SAD)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized clinical trial examines the feasibility, acceptability, mechanism, and&#xD;
      relative efficacy of two &quot;doses&quot; (standard 4-week/8 session vs. extended 8-week/12-session)&#xD;
      of a recently developed computer-based therapy in individuals with social anxiety disorder&#xD;
      (SAD). The purpose of this study is to assess whether a brief computer-based research&#xD;
      treatment, provided in 30 minutes sessions, helps improve social anxiety symptoms, and by&#xD;
      what mechanism. The study will also assess the effect of research treatments on brain&#xD;
      activity using magnetic resonance imaging (MRI).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Computer-based task involving free viewing of faces and listening to music</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcomes assessor will not be informed as to whether a participant is randomized to 4 or 8 weeks of treatment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Percent Dwell Time on Threat Faces</measure>
    <time_frame>baseline to week 8</time_frame>
    <description>Percent dwell time on threat faces was computed as the ratio of gaze dwell time on threat faces to total dwell time on all faces as measured by eye tracking during treatment sessions. Change in percent dwell time is the value at week 8 minus value at baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Total Score of Liebowitz Social Anxiety Scale (LSAS)</measure>
    <time_frame>Baseline to week 8</time_frame>
    <description>Clinician-rated scale scoring anxiety (0, none to 3, severe) and avoidance (0,none to 3, severe) in 24 social situations for a total score of 0 to 144. Higher scores indicate greater social anxiety.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Total Score of Social Phobia Inventory (SPIN)</measure>
    <time_frame>baseline to week 8</time_frame>
    <description>The Social Phobia Inventory (SPIN) is a self-rated questionnaire used to assess severity of social anxiety disorder. 17 items related to social anxiety each rated on a score of 0 to 4, with a minimum total score of 0 (least social anxiety), and a maximum total score of 68 (most social anxiety).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Total Score of Quality of Life Enjoyment &amp; Satisfaction Questionnaire</measure>
    <time_frame>baseline to week 8</time_frame>
    <description>Quality of Life Enjoyment &amp; Satisfaction Questionnaire (Q-LES-Q): self-rated assessment of quality of life. 16 items related to life quality, each rated on a score of 1 (very poor) to 5 (very good), with a minimum total score of 16, and a maximum total score of 80.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Total Score of the Revised Social Anhedonia Scale</measure>
    <time_frame>baseline to week 8</time_frame>
    <description>40-item self-rated social anhedonia scale. Items are comprised of statements that participants agree or disagree with, by answering &quot;yes&quot;(1), or &quot;no&quot;(0), with some items reverse-coded. The minimum score is 0 (least social anhedonia); maximum score is 40 (most social anhedonia)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Total Score of the Snaith Hamilton Pleasure Scale</measure>
    <time_frame>baseline to week 8</time_frame>
    <description>Snaith Hamilton Pleasure Scale (SHAPS). Fourteen-item self-rated anhedonia scale. Items are comprised of statements that participants rate as &quot;strongly disagree&quot; (1), &quot;disagree&quot; (2), &quot;agree&quot; (3), or &quot;strongly agree&quot; (4). The lowest possible score was 14, the highest possible score was 56 (greatest anhedonia)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Total Score of the Hamilton Rating Scale for Depression - 17 Item Version</measure>
    <time_frame>baseline to week 8</time_frame>
    <description>Hamilton Rating Scale for Depression -17 item version. This standard scale will be used to assess severity of depression, minimum score is 0 (least depression); maximum score is 50 (greatest depression).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression-Change Scale</measure>
    <time_frame>week 8</time_frame>
    <description>Clinical Global Impression-Change Scale: An observer rating of overall clinical change, with rating from 1 (very much improved) to 7 (very much worse). Responder category is defined by a score of 1 or 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Blood Oxygen Level Dependent (BOLD) Signal as Measured by Functional Magnetic Resonance Imaging (fMRI) During Resting State and During Social Reward and Attention Control Tasks</measure>
    <time_frame>baseline to week 2</time_frame>
    <description>brain activation as measured by fMRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Reward Learning as Assessed by Probabilistic Reward Task</measure>
    <time_frame>baseline to week 8</time_frame>
    <description>Reward learning is operationalized as the increase in response bias during the final block relative to the first block of the task, and decreased reward learning has been associated with social anhedonia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Evoked Response Potentials: Cue P3 and Feedback Negativity and P3</measure>
    <time_frame>baseline to week 2</time_frame>
    <description>evoked response potentials during social reward task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Error Related Negativity</measure>
    <time_frame>baseline to week 2</time_frame>
    <description>evoked response potentials during flanker task</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Social Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>4-week computer-based treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 4-week (8-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8-week computer-based treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An 8-week (12-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks, and then once a week for the subsequent four weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>computer-based treatment</intervention_name>
    <description>30 minute sessions of free viewing of faces and listening to music</description>
    <arm_group_label>4-week computer-based treatment</arm_group_label>
    <arm_group_label>8-week computer-based treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females between the ages of 18 and 60&#xD;
&#xD;
          -  Current primary diagnosis of SAD&#xD;
&#xD;
          -  Score of at least 50 on the Liebowitz Social Anxiety Scale (Self-rated version)&#xD;
&#xD;
          -  Fluent in English and willing and able to give informed written consent and&#xD;
             participate responsibly in the protocol&#xD;
&#xD;
          -  Normal or corrected-to-normal vision&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective&#xD;
             disorder, or bipolar disorder&#xD;
&#xD;
          -  Current severe depression&#xD;
&#xD;
          -  Suicidal ideation or behavior&#xD;
&#xD;
          -  Current diagnosis of posttraumatic stress disorder, obsessive-compulsive disorder,&#xD;
             bipolar disorder, manic episode or tic disorder&#xD;
&#xD;
          -  Current or past organic mental disorder, seizure disorder, epilepsy or brain injury&#xD;
&#xD;
          -  Current unstable or untreated medical illness&#xD;
&#xD;
          -  Severe alcohol use disorder, severe cannabis use disorder, and any severity of other&#xD;
             substance use disorder (except nicotine use disorders allowed)&#xD;
&#xD;
          -  Use of psychiatric medication in the past month other than a stable dose of selective&#xD;
             serotonin reuptake inhibitors (SSRIs) for a least 3 months&#xD;
&#xD;
          -  Any concurrent cognitive behavioral therapy; other psychotherapy that was initiated in&#xD;
             the past 3 months&#xD;
&#xD;
          -  Pregnancy, or plans to become pregnant during the period of the study - will be&#xD;
             assessed by urine&#xD;
&#xD;
          -  Contraindication to MRI scanning:&#xD;
&#xD;
          -  Paramagnetic metallic implants or devices contraindicating magnetic resonance imaging&#xD;
             or any other non-removable paramagnetic metal in the body (e.g. pacemaker,&#xD;
             paramagnetic metallic prosthesis, surgical clips, shrapnel, necessity for constant&#xD;
             medicinal patch, some tattoos)&#xD;
&#xD;
          -  Being unable to tolerate the scanning procedures (i.e., severe obesity,&#xD;
             claustrophobia)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franklin Schneier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York State Psychiatric Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York State Psychiatric Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Chevallier C, Tonge N, Safra L, Kahn D, Kohls G, Miller J, Schultz RT. Measuring Social Motivation Using Signal Detection and Reward Responsiveness. PLoS One. 2016 Dec 1;11(12):e0167024. doi: 10.1371/journal.pone.0167024. eCollection 2016.</citation>
    <PMID>27907025</PMID>
  </reference>
  <reference>
    <citation>Cisler JM, Koster EH. Mechanisms of attentional biases towards threat in anxiety disorders: An integrative review. Clin Psychol Rev. 2010 Mar;30(2):203-16. doi: 10.1016/j.cpr.2009.11.003. Epub 2009 Dec 14. Review.</citation>
    <PMID>20005616</PMID>
  </reference>
  <reference>
    <citation>Gur RC, Schroeder L, Turner T, McGrath C, Chan RM, Turetsky BI, Alsop D, Maldjian J, Gur RE. Brain activation during facial emotion processing. Neuroimage. 2002 Jul;16(3 Pt 1):651-62.</citation>
    <PMID>12169250</PMID>
  </reference>
  <reference>
    <citation>Heeren A, Mogoașe C, Philippot P, McNally RJ. Attention bias modification for social anxiety: A systematic review and meta-analysis. Clin Psychol Rev. 2015 Aug;40:76-90. doi: 10.1016/j.cpr.2015.06.001. Epub 2015 Jun 6. Review.</citation>
    <PMID>26080314</PMID>
  </reference>
  <reference>
    <citation>Klumpp H, Angstadt M, Phan KL. Shifting the focus of attention modulates amygdala and anterior cingulate cortex reactivity to emotional faces. Neurosci Lett. 2012 Apr 18;514(2):210-3. doi: 10.1016/j.neulet.2012.03.003. Epub 2012 Mar 8.</citation>
    <PMID>22425719</PMID>
  </reference>
  <reference>
    <citation>Klumpp H, Post D, Angstadt M, Fitzgerald DA, Phan KL. Anterior cingulate cortex and insula response during indirect and direct processing of emotional faces in generalized social anxiety disorder. Biol Mood Anxiety Disord. 2013 Apr 2;3:7. doi: 10.1186/2045-5380-3-7. eCollection 2013.</citation>
    <PMID>23547713</PMID>
  </reference>
  <reference>
    <citation>Lazarov A, Abend R, Bar-Haim Y. Social anxiety is related to increased dwell time on socially threatening faces. J Affect Disord. 2016 Mar 15;193:282-8. doi: 10.1016/j.jad.2016.01.007. Epub 2016 Jan 12.</citation>
    <PMID>26774515</PMID>
  </reference>
  <reference>
    <citation>Lazarov A, Pine DS, Bar-Haim Y. Gaze-Contingent Music Reward Therapy for Social Anxiety Disorder: A Randomized Controlled Trial. Am J Psychiatry. 2017 Jul 1;174(7):649-656. doi: 10.1176/appi.ajp.2016.16080894. Epub 2017 Jan 20.</citation>
    <PMID>28103714</PMID>
  </reference>
  <reference>
    <citation>Linetzky M, Pergamin-Hight L, Pine DS, Bar-Haim Y. Quantitative evaluation of the clinical efficacy of attention bias modification treatment for anxiety disorders. Depress Anxiety. 2015 Jun;32(6):383-91. doi: 10.1002/da.22344. Epub 2015 Feb 24. Erratum in: Depress Anxiety. 2018 Jan;35(1):111-112.</citation>
    <PMID>25708991</PMID>
  </reference>
  <reference>
    <citation>Mogoaşe C, David D, Koster EH. Clinical efficacy of attentional bias modification procedures: an updated meta-analysis. J Clin Psychol. 2014 Dec;70(12):1133-57. doi: 10.1002/jclp.22081. Epub 2014 Mar 20.</citation>
    <PMID>24652823</PMID>
  </reference>
  <reference>
    <citation>Morrison AS, Heimberg RG. Social anxiety and social anxiety disorder. Annu Rev Clin Psychol. 2013;9:249-74. doi: 10.1146/annurev-clinpsy-050212-185631. Review.</citation>
    <PMID>23537485</PMID>
  </reference>
  <reference>
    <citation>Richey JA, Rittenberg A, Hughes L, Damiano CR, Sabatino A, Miller S, Hanna E, Bodfish JW, Dichter GS. Common and distinct neural features of social and non-social reward processing in autism and social anxiety disorder. Soc Cogn Affect Neurosci. 2014 Mar;9(3):367-77. doi: 10.1093/scan/nss146. Epub 2012 Dec 7.</citation>
    <PMID>23223206</PMID>
  </reference>
  <reference>
    <citation>Spreckelmeyer KN, Krach S, Kohls G, Rademacher L, Irmak A, Konrad K, Kircher T, Gründer G. Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women. Soc Cogn Affect Neurosci. 2009 Jun;4(2):158-65. doi: 10.1093/scan/nsn051. Epub 2009 Jan 27.</citation>
    <PMID>19174537</PMID>
  </reference>
  <reference>
    <citation>Van Bockstaele B, Verschuere B, Tibboel H, De Houwer J, Crombez G, Koster EH. A review of current evidence for the causal impact of attentional bias on fear and anxiety. Psychol Bull. 2014 May;140(3):682-721. doi: 10.1037/a0034834. Epub 2013 Nov 4. Review.</citation>
    <PMID>24188418</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 22, 2018</study_first_submitted>
  <study_first_submitted_qc>January 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2018</study_first_posted>
  <results_first_submitted>July 21, 2020</results_first_submitted>
  <results_first_submitted_qc>August 10, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 11, 2020</results_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York State Psychiatric Institute</investigator_affiliation>
    <investigator_full_name>Franklin Schneier</investigator_full_name>
    <investigator_title>Research Psychiatrist</investigator_title>
  </responsible_party>
  <keyword>SAD</keyword>
  <keyword>Social Anxiety</keyword>
  <keyword>Social Phobia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Phobia, Social</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared through the National Database for Clinical Trials related to Mental Illness (NDCT). We will generate a Global Unique Identifier (GUID) for each participant. The key clinical rating scale measures (LSAS, SPIN, QLESQ, HRSD) are all included.</ipd_description>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Raw data will be submitted semi-annually every January 15 and July 15.</ipd_time_frame>
    <ipd_access_criteria>see URL below for criteria</ipd_access_criteria>
    <ipd_url>https://nda.nih.gov/</ipd_url>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 20, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/22/NCT03415022/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>9 participants discontinued the study after initial evaluation but before treatment randomization:&#xD;
5 discontinued due to scheduling difficulties&#xD;
2 discontinued due to COVID-19 research suspension&#xD;
2 discontinued due to difficulties calibrating eye tracker used for treatment sessions</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>4-week Computer-based Treatment</title>
          <description>A 4-week (8-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks.&#xD;
Computer-based treatment: 30 minute sessions of free viewing of faces and listening to music</description>
        </group>
        <group group_id="P2">
          <title>8-week Computer-based Treatment</title>
          <description>An 8-week (12-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks, and then once a week for the subsequent four weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>COVID-19 Suspension</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants who started treatment sessions</population>
      <group_list>
        <group group_id="B1">
          <title>4-week Computer-based Treatment</title>
          <description>A 4-week (8-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks.&#xD;
computer-based treatment: 30 minute sessions of free viewing of faces and listening to music</description>
        </group>
        <group group_id="B2">
          <title>8-week Computer-based Treatment</title>
          <description>An 8-week (12-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks, and then once a week for the subsequent four weeks.&#xD;
computer-based treatment: 30 minute sessions of free viewing of faces and listening to music</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="41"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.7" spread="5.08"/>
                    <measurement group_id="B2" value="29.15" spread="7.13"/>
                    <measurement group_id="B3" value="28.61" spread="6.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Liebowitz Social Anxiety Scale</title>
          <description>This clinician-reported scale is used to assess social anxiety. Participants were provided with a list of 24 social situations and rated their anxiety in that situation on a scale from 0-3, and their avoidance of that situation on a scale from 0-3. The measure is scored by adding the total of anxiety ratings and avoidance ratings (scores range from 0-144).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.8" spread="16.81"/>
                    <measurement group_id="B2" value="87.6" spread="11.32"/>
                    <measurement group_id="B3" value="86.05" spread="14.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Percent Dwell Time on Threat Faces</title>
        <description>Percent dwell time on threat faces was computed as the ratio of gaze dwell time on threat faces to total dwell time on all faces as measured by eye tracking during treatment sessions. Change in percent dwell time is the value at week 8 minus value at baseline.</description>
        <time_frame>baseline to week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>4-week Computer-based Treatment</title>
            <description>A 4-week (8-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks.&#xD;
Computer-based treatment: 30 minute sessions of free viewing of faces and listening to music</description>
          </group>
          <group group_id="O2">
            <title>8-week Computer-based Treatment</title>
            <description>An 8-week (12-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks, and then once a week for the subsequent four weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Percent Dwell Time on Threat Faces</title>
          <description>Percent dwell time on threat faces was computed as the ratio of gaze dwell time on threat faces to total dwell time on all faces as measured by eye tracking during treatment sessions. Change in percent dwell time is the value at week 8 minus value at baseline.</description>
          <units>percentage of dwell time on threat faces</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.7" spread="20.6"/>
                    <measurement group_id="O2" value="27.1" spread="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Total Score of Liebowitz Social Anxiety Scale (LSAS)</title>
        <description>Clinician-rated scale scoring anxiety (0, none to 3, severe) and avoidance (0,none to 3, severe) in 24 social situations for a total score of 0 to 144. Higher scores indicate greater social anxiety.</description>
        <time_frame>Baseline to week 8</time_frame>
        <population>Participants who completed 8 weeks of study participation</population>
        <group_list>
          <group group_id="O1">
            <title>4-week Computer-based Treatment</title>
            <description>A 4-week (8-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks.&#xD;
Computer-based treatment: 30 minute sessions of free viewing of faces and listening to music</description>
          </group>
          <group group_id="O2">
            <title>8-week Computer-based Treatment</title>
            <description>An 8-week (12-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks, and then once a week for the subsequent four weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Total Score of Liebowitz Social Anxiety Scale (LSAS)</title>
          <description>Clinician-rated scale scoring anxiety (0, none to 3, severe) and avoidance (0,none to 3, severe) in 24 social situations for a total score of 0 to 144. Higher scores indicate greater social anxiety.</description>
          <population>Participants who completed 8 weeks of study participation</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.68" spread="32.44"/>
                    <measurement group_id="O2" value="22.38" spread="22.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Total Score of Social Phobia Inventory (SPIN)</title>
        <description>The Social Phobia Inventory (SPIN) is a self-rated questionnaire used to assess severity of social anxiety disorder. 17 items related to social anxiety each rated on a score of 0 to 4, with a minimum total score of 0 (least social anxiety), and a maximum total score of 68 (most social anxiety).</description>
        <time_frame>baseline to week 8</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Total Score of Quality of Life Enjoyment &amp; Satisfaction Questionnaire</title>
        <description>Quality of Life Enjoyment &amp; Satisfaction Questionnaire (Q-LES-Q): self-rated assessment of quality of life. 16 items related to life quality, each rated on a score of 1 (very poor) to 5 (very good), with a minimum total score of 16, and a maximum total score of 80.</description>
        <time_frame>baseline to week 8</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Total Score of the Revised Social Anhedonia Scale</title>
        <description>40-item self-rated social anhedonia scale. Items are comprised of statements that participants agree or disagree with, by answering &quot;yes&quot;(1), or &quot;no&quot;(0), with some items reverse-coded. The minimum score is 0 (least social anhedonia); maximum score is 40 (most social anhedonia)</description>
        <time_frame>baseline to week 8</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Total Score of the Snaith Hamilton Pleasure Scale</title>
        <description>Snaith Hamilton Pleasure Scale (SHAPS). Fourteen-item self-rated anhedonia scale. Items are comprised of statements that participants rate as &quot;strongly disagree&quot; (1), &quot;disagree&quot; (2), &quot;agree&quot; (3), or &quot;strongly agree&quot; (4). The lowest possible score was 14, the highest possible score was 56 (greatest anhedonia)</description>
        <time_frame>baseline to week 8</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Total Score of the Hamilton Rating Scale for Depression - 17 Item Version</title>
        <description>Hamilton Rating Scale for Depression -17 item version. This standard scale will be used to assess severity of depression, minimum score is 0 (least depression); maximum score is 50 (greatest depression).</description>
        <time_frame>baseline to week 8</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Global Impression-Change Scale</title>
        <description>Clinical Global Impression-Change Scale: An observer rating of overall clinical change, with rating from 1 (very much improved) to 7 (very much worse). Responder category is defined by a score of 1 or 2.</description>
        <time_frame>week 8</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Blood Oxygen Level Dependent (BOLD) Signal as Measured by Functional Magnetic Resonance Imaging (fMRI) During Resting State and During Social Reward and Attention Control Tasks</title>
        <description>brain activation as measured by fMRI</description>
        <time_frame>baseline to week 2</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Reward Learning as Assessed by Probabilistic Reward Task</title>
        <description>Reward learning is operationalized as the increase in response bias during the final block relative to the first block of the task, and decreased reward learning has been associated with social anhedonia</description>
        <time_frame>baseline to week 8</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Evoked Response Potentials: Cue P3 and Feedback Negativity and P3</title>
        <description>evoked response potentials during social reward task</description>
        <time_frame>baseline to week 2</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Error Related Negativity</title>
        <description>evoked response potentials during flanker task</description>
        <time_frame>baseline to week 2</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>20 weeks (8 weeks of active treatment phase and 3 month follow-up phase)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>4-week Computer-based Treatment</title>
          <description>A 4-week (8-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks.&#xD;
Computer-based treatment: 30 minute sessions of free viewing of faces and listening to music</description>
        </group>
        <group group_id="E2">
          <title>8-week Computer-based Treatment</title>
          <description>An 8-week (12-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks, and then once a week for the subsequent four weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Franklin Schneier</name_or_title>
      <organization>New York State Psychiatric Institue</organization>
      <phone>646-774-8041</phone>
      <email>Franklin.Schneier@nyspi.columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

